Glenmark Launches Generic Eye Itch Treatment in US

New Delhi, Aug 19 (PTI) Glenmark Pharmaceuticals on Monday said its US-based subsidiary has introduced a generic medication used for eye itching.

Glenmark Therapeutics Inc, USA has launched Olopatadine Hydrochloride Ophthalmic Solution (OTC) in the US market, the Mumbai-based drug maker said in a regulatory filing.

Fabio Moreno, Head of OTC Sales & Marketing, Glenmark Pharmaceuticals Inc, said the launch of Olopatadine Ophthalmic Solution (USP, 0.1 per cent), addresses a growing demand for a new supplier in this category.

"This addition highlights our commitment to meeting market needs and providing high-quality over-the-counter solutions for our customers," Moreno said.